NCT Number: NCT02219074
Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
Prospective, multicenter study with multiple arms to examine the safety and effectiveness of the Sebacia Acne Treatment System for the treatment of acne vulgaris.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year–35 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Specjalistyczny Gabinet Dermatologiczny, Krakow, Poland
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- clinical diagnosis of moderate to severe acne vulgaris
Exclusion criteria
- use of oral retinoid therapy in the past 12 months
- pregnancy, lactating, or planning to become pregnant
- excessive scarring in the treatment area, or other condition that would impact the ability to evaluate acne
Treatment and study plan
Vehicle and laser treatment
DevicePrimary outcomes
-
Change in inflammatory lesion count
Time frame: Week 12
-
Number of adverse events
Time frame: Screening to 26 weeks
Secondary outcomes
-
Investigator Global Assessment
Time frame: Week 12
Sponsors and collaborators
Lead sponsor
Sebacia, Inc.
Industry
Registry information
Official study title
A Feasibility Study to Evaluate the Safety and Preliminary Efficacy of the Sebacia Acne Treatment System for the Treatment of Acne Vulgaris
Important dates
- Study start
- 2011
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Aug 18, 2014
- Registry last updated
- Sep 7, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
NCT05080764
Acne Vulgaris, Acneiform Eruptions
Fountain Valley, California, United States
View Trial DetailsAI-Generated Acne Vulgaris Learning Material Study
NCT07652112
Acne Vulgaris, Acneiform Eruptions
Kayseri, Turkey (Türkiye)
View Trial DetailsA Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients
NCT06415279
Acne Vulgaris, Acneiform Eruptions
High Point, North Carolina, United States
View Trial DetailsRandomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel 7.5% in Patients With Acne Vulgaris
NCT07244887
Acne Vulgaris, Acneiform Eruptions
Istanbul, Turkey (Türkiye)
View Trial Details